Skip to content
Disclosery

Royalty Pharma Sub-Manager, LLC: BHVN position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Royalty Pharma Sub-Manager, LLC on BHVN, newest first. How the timeline and the estimate are built.

Royalty Pharma Sub-Manager, LLC held 2,936,507 BHVN shares at 2026-06-30 per its 13F-HR/A filed 2026-08-21.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F/A 2,936,507 shares
    Change vs previous 13F 0 shares

    18.06% of the 13F portfolio, value $43,695,224.

    13F-HR/A 0002081668-26-000018 filed by Royalty Pharma Sub-Manager, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F/A 2,936,507 shares
    Change vs previous 13F 0 shares

    14.38% of the 13F portfolio, value $24,842,849.

    13F-HR/A 0002081668-26-000017 filed by Royalty Pharma Sub-Manager, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F/A 2,936,507 shares
    Change vs previous 13F not available

    19.35% of the 13F portfolio, value $33,153,164.

    13F-HR/A 0002081668-26-000015 filed by Royalty Pharma Sub-Manager, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).